Bollard Group LLC

BOSTON, MA · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 13, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$3.32B2026 Q3+ $6.9M options (notional, not included)
Positions303
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.66.3%

Bollard Group LLC reported 303 positions worth $3.32B as of September 30, 2026 (13F filed November 13, 2026). Largest holding: BSX (24.2%). Biggest move: new buy NCLH ($19.4M).

10 / 303 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 BSXBoston Scientific$804.1M24.20%18,420,720——+0.1%
▸ 2 LLYEli Lilly$228.4M6.87%197,356——+23.7%
▸ 3 AMZNAmazon$189.9M5.71%762,206——+3.5%
▸ 4 CATCaterpillar$189.7M5.71%233,911——-29.6%
▸ 5 SCCOSouthern Copper Corp/$184.5M5.55%910,314——-24.1%
▸ 6 SPYSPDR S&P 500$182.0M5.48%238,673——-3.0%
▸ 7 GOOGAlphabet$150.4M4.53%441,432——-17.5%
▸ 8 MSFTMicrosoft$147.4M4.43%287,356——+1.0%
▸ 9 OKEOneok$64.6M1.94%757,436——+3.3%
▸ 10 EPDEnterprise Products Partners$61.1M1.84%1,716,835——+5.1%

Pro Feature

The remaining 293 positions with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does Bollard Group LLC hold as of Q3 2026?

Bollard Group LLC reported 303 positions worth $3.32B in its Q3 2026 13F filing. Largest positions: BSX (24.2%), LLY (6.9%), AMZN (5.7%), CAT (5.7%) and SCCO (5.6%).

What did Bollard Group LLC buy in Q3 2026?

New positions: NCLH, BOSTON SCIENTIFIC CORP, XOM, SPCX and QXO. Added to: NVDA, SCCO, EPD, OKE and PAA (125 in all).

What did Bollard Group LLC sell in Q3 2026?

Reduced: TMO, IT, AEP, TECX and PEG (74 in all). Sold out entirely: EXMOC, CARG, PRME, KRE and NOW (11 in all).

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.